Patients with higher BMI had lower natriuretic peptide levels (irrespective of the presence of atrial fibrillation) but a higher urinary cGMP/BNP ratio (as a marker of tissue responsiveness to natriuretic peptides). This evidence concerns the gene NPPB and atrial fibrillation.